Markov Models in Medical Decision Making: A Practical Guide

Medical Decision Making

Volumn 13, Issue 4, 1993, Pages 322-338

  Sonnenberg, Frank A ^a   Beck, J Robert ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COHORT ANALYSIS; DECISION THEORY; LIFE EVENT; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; PROBABILITY; REVIEW; SYSTEM ANALYSIS;

ADULT; ANTICOAGULANTS; CASE REPORT; COHORT STUDIES; DECISION SUPPORT TECHNIQUES; EMBOLISM; HEART VALVE PROSTHESIS; HEMORRHAGE; HUMAN; KIDNEY TRANSPLANTATION; MALE; MARKOV CHAINS; MONTE CARLO METHOD; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; QUALITY OF LIFE; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL RATE;

EID: 0027772390     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X9301300409     Document Type: Article

References (18)

1. Mehrez A., Gafni A. Quality-adjusted life years, utility theory, and healthy-years equivalents. Med Decis Making. 1989; 9: 142-9. Beck J.R., Kassirer JP, Pauker SG 2 A convenient approximation of life expectancy (the “DEALE”). I. Validation of the model. Am J Med. 1982; 73: 883-8.
2. Gompertz B. On the nature of the function expressive of the law of human mortality. Philos Trans R Soc London. 1825; 115: 513-85.
3. National Center for Health Statistics. Vital Statistics of the United States, 1988. Vol II, Mortality, Part A, Section 6. Washington, Public Health Service, 1991.
4. Beck J.R., Pauker S.G. The Markov process in medical prognosis. Med Decis Making. 1983; 3: 419-58.
5. Eckman M.H., Beshansky J.R., Durand-Zaleski I., Levine H.J., Pauker S.G. Anticoagulation for noncardiac procedures in patients with prosthetic heart valves. Does low risk mean high cost? JAMA, 1990; 263: 1513-21.
6. Wong J.B., Sonnenberg F.A., Salem D., Pauker S.G. Myocardial revascularization for chronic stable angina: an analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989. Ann Intern Med. 1990; 113: 852-71.
7. Hillner B.E., Smith T.J., Desch C.E. Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision analysis while awaiting clinical trial results. JAMA. 1992; 267: 2055-61.
8. Birkmeyer J.D., Marrin C.A., O'Connor G-T. Should patients with Bjork-Shiley valves undergo prophylactic replacement? Lancet. 1992; 340: 520-3.
9. Weinstein M.C., Stason W.B. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977; 296: 716-21.
10. Detsky A.S., Naglie I.G. A clinician's guide to cost-effectiveness analysis. Ann Intern Med. 1990; 113: 147-54.
11. Lau J., Kassirer J.P., Pauker S.G. DECISION MAKER 3.0: improved decision analysis by personal computer. Med Decis Making. 1983; 3: 39-43.
12. Goldman L. Cardiac risks and complications of noncardiac surgery. Ann Intern Med. 1983; 98: 504-13.
13. Kemeny J.B., Snell J.L. Finite Markov Chains. New York: Springer-Verlag, 1976.
14. Hollenberg J.P. Markov cycle trees: a new representation for complex Markov processes (abstr). Med Decis Making. 1984; 4: 529. 16. Cucharal GJ, Levey AS, Pauker SG 16 Kidney Failure or Cancer: Should Immunosuppression Be Continued in a Transplant Patient with Malignant Melanoma? Med Decis Making. 1984; 4: 82-107.
15. Kassirer J.P., Sonnenberg F.A. Decision analysis. In Kelley WN, ed. Textbook of Internal Medicine. Philadelphia: J. B. Lippincott, 1988, 1991.
16. Sonnenberg F.A., Pauker S.G. Decision Maker: an advanced personal computer tool for clinical decision analysis. Proceedings of the Eleventh Annual Symposium on Computer Applications in Medical Care, Washington, D.C.: IEEE Computer Society, 1987.
17. Hollenberg J. SMLTREE: The All Purpose Decision Tree Builder. Boston: Pratt Medical Group; 1985.
18. Sonnenberg F.A., Wong J.B. Fine-tuning Markov models for life-expectancy calculations. Med Decis Making. 1993; 13: 170-2.